Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Impaired Renal Function and Healthy Subjects”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03192111
What this trial is testing

Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal ImpairmentHealthy Volunteer
Syndax Pharmaceuticals 40
Early research (Phase 1)Study completedNCT02172118
What this trial is testing

BI 1744 CL in Patients With Severe Renal Impairment in Comparison to Subjects With Normal Renal Function

Who this might be right for
Healthy
Boehringer Ingelheim 22
Early research (Phase 1)Study completedNCT02427035
What this trial is testing

CSL112 in Healthy Adults and in Adults With Moderate Renal Impairment

Who this might be right for
Acute Myocardial Infarction
CSL Behring 32
Early research (Phase 1)Study completedNCT02647918
What this trial is testing

Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function

Who this might be right for
Renal ImpairmentHealthy
Lexicon Pharmaceuticals 50
Early research (Phase 1)Study completedNCT03443063
What this trial is testing

Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment

Who this might be right for
Renal Impairment
Eisai Inc. 16
Early research (Phase 1)WithdrawnNCT03545087
What this trial is testing

Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants

Who this might be right for
Renal Insufficiency
Eli Lilly and Company
Early research (Phase 1)Study completedNCT03259087
What this trial is testing

Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 42
Early research (Phase 1)Study completedNCT01462136
What this trial is testing

PK Study of ACHN-490 Injection in Renally Impaired Subjects

Who this might be right for
Renal Insufficiency
Achaogen, Inc. 24
Early research (Phase 1)Study completedNCT01571999
What this trial is testing

Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 17
Early research (Phase 1)Study completedNCT02084199
What this trial is testing

Study to Evaluate GLPG0634 in Subjects With Renal Impairment Compared to Healthy Subjects

Who this might be right for
Renal Impairment
Lakefront Biotherapeutics NV 24
Early research (Phase 1)Study completedNCT03961932
What this trial is testing

Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal ImpairmentHealthy Participants
ObsEva SA 33
Early research (Phase 1)Study completedNCT03844555
What this trial is testing

Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients

Who this might be right for
Renal ImpairmentRenal InsufficiencyKidney Diseases+1 more
Genfit 23
Early research (Phase 1)Study completedNCT01791855
What this trial is testing

PF-04634817 Renal Impairment Study

Who this might be right for
Renal Insufficiency
Pfizer 32
Early research (Phase 1)Study completedNCT02347046
What this trial is testing

Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)

Who this might be right for
Renal InsufficiencyHealthy
Fuji Yakuhin Co., Ltd. 18
Early research (Phase 1)Ended earlyNCT01675973
What this trial is testing

Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine

Who this might be right for
Severe Renal Impairment
Gilead Sciences 4
Not applicableStudy completedNCT01623661
What this trial is testing

Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney Disease

Who this might be right for
Nephropathy
Regional Hospital Holstebro 47
Early research (Phase 1)Study completedNCT04476849
What this trial is testing

Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal Function

Who this might be right for
Healthy VolunteersRenal Impairment
Astellas Pharma Global Development, Inc. 27
Early research (Phase 1)Study completedNCT00999336
What this trial is testing

Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 32
Early research (Phase 1)Study completedNCT03660241
What this trial is testing

A Renal Impairment Study for PF-04965842

Who this might be right for
Renal Impairment
Pfizer 23
Early research (Phase 1)Study completedNCT05704556
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment

Who this might be right for
Pain
Vertex Pharmaceuticals Incorporated 38
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation